rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
1999-10-8
|
pubmed:abstractText |
The upper limit of the natural decline in creatinine clearance is 1 ml/min/year. To define the loss of renal function, we started a long-term assessment of patients with ovarian cancer treated by whole abdominal irradiation (WAI) with preceding cisplatin chemotherapy (CDDP) and second-look laparotomy (SLL).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0923-7534
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
677-83
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10442190-Abdomen,
pubmed-meshheading:10442190-Adolescent,
pubmed-meshheading:10442190-Adult,
pubmed-meshheading:10442190-Aged,
pubmed-meshheading:10442190-Aged, 80 and over,
pubmed-meshheading:10442190-Antineoplastic Agents,
pubmed-meshheading:10442190-Cisplatin,
pubmed-meshheading:10442190-Combined Modality Therapy,
pubmed-meshheading:10442190-Creatinine,
pubmed-meshheading:10442190-Female,
pubmed-meshheading:10442190-Follow-Up Studies,
pubmed-meshheading:10442190-Glomerular Filtration Rate,
pubmed-meshheading:10442190-Humans,
pubmed-meshheading:10442190-Kidney,
pubmed-meshheading:10442190-Middle Aged,
pubmed-meshheading:10442190-Ovarian Neoplasms,
pubmed-meshheading:10442190-Radiotherapy
|
pubmed:year |
1999
|
pubmed:articleTitle |
Long-term evolution of renal function in patients with ovarian cancer after whole abdominal irradiation with or without preceding cisplatin.
|
pubmed:affiliation |
Department of Radiation Oncology, University of Bern, Inselspital, Switzerland.
|
pubmed:publicationType |
Journal Article
|